SCOPUS 정보 검색 플랫폼

Volumn 99, Issue 2, 2002, Pages 450-456

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: A prospective, multicenter study

(10) Mannucci, Pier M a,b,c,d,e,f,g Chediak, Juan a,b,c,d,e,f,g Hanna, Wahid a,b,c,d,e,f,g Byrnes, John a,b,c,d,e,f,g Ledford, Marlies a,b,c,d,e,f,g Ewenstein, Bruce M a,b,c,d,e,f,g Retzios, Anastassios D a,b,c,d,e,f,g Kapelan, Barbara A a,b,c,d,e,f,g Schwartz, Richard S a,b,c,d,e,f,g Kessler, Craig a,b,c,d,e,f,g

a UNIVERSITY OF MILAN (Italy)

b ADVOCATE ILLINOIS MASONIC MEDICAL CENTER (United States)

c UNIVERSITY OF TENNESSEE (United States)

d UNIVERSITY OF MIAMI (United States)

e BRIGHAM AND WOMEN S HOSPITAL (United States)

f Grifols SA (United States)

g GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ERYTHEMA MULTIFORME; FEMALE; HEAT TREATMENT; HEMOSTASIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SURGICAL RISK; THROMBOPHLEBITIS; THROMBOSIS; VON WILLEBRAND DISEASE;

EID: 0037079717 PISSN: 00064971 EISSN: None Source Type: Journal
DOI: 10.1182/blood.V99.2.450 Document Type: Article

Times cited : (187)

References (26)

1
- 0023164845
- Epidemiological investigation of the prevalence of von Willebrand's disease
- (1987) Blood , vol.69 , pp. 454-459
- Rodeghiero, F.¹ Castaman, G.² Dini, E.³

2
- 0027458101
- Prevalence of von Willebrand disease in children: A multiethnic study
- (1993) J Pediatr , vol.123 , pp. 893-898
- Werner, E.J.¹ Broxson, E.H.² Tucker, E.L.³ Giroux, D.S.⁴ Shults, J.⁵ Abshire, T.C.⁶

3
- 0033858187
- Impact, diagnosis and treatment of von Willebrand disease
- (2000) Thromb Haemost , vol.84 , pp. 160-174
- Sadler, J.E.¹ Mannucci, P.M.² Berntorp, E.³

4
- 0017336844
- 1-Deamino-8-D arginine vasopressin: A new pharmacological approach in the management of hemophilia and von Willebrand disease
- (1997) Lancet , vol.1 , pp. 869-872
- Mannucci, P.M.¹ Ruggeri, Z.M.² Pareti, F.I.³ Capitanio, A.⁴

5
- 0030767469
- Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years
- (1997) Blood , vol.20 , pp. 2515-2521
- Mannucci, P.M.¹

6
- 0026713114
- Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)
- (1992) Br J Haematol , vol.82 , pp. 87-93
- Mannucci, P.M.¹ Bettega, D.² Cattaneo, M.³

7
- 0026591332
- Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease
- (1992) Vox Sang , vol.62 , pp. 193-199
- Rodeghiero, F.¹ Castaman, G.² Meyer, D.³ Mannucci, P.M.⁴

8
- 0023923139
- Hemostatic effect of a heat-treated factor VIII concentrate (Haemate P) in von Willebrand's disease
- (1988) Blut , vol.56 , pp. 171-178
- Fukui, H.¹ Nishino, M.² Terada, S.³

9
- 0025281796
- Clinical and laboratory evaluation of the treatment of von Willebrand's disease patients with heat-treated factor VIII concentrate (BPL 8Y)
- (1990) Br J Haematol , vol.75 , pp. 228-233
- Pasi, K.J.¹ William, M.D.² Enayat, M.S.³ Hill, F.G.H.⁴

10
- 0027079911
- Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III
- (1992) Ann Hematol , vol.65 , pp. 253-259
- Lethagen, S.¹ Berntorp, E.² Nilsson, I.M.³

11
- 0028010958
- The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease
- (1994) Thromb Haemost , vol.71 , pp. 173-179
- Hanna, W.T.¹ Bona, R.D.² Zimmerman, C.E.³ Carta, C.A.⁴ Hebert, G.Z.⁵ Rickles, F.R.⁶

12
- 0031797825
- Pharmacokinetics, efficacy and safety of Humate-P® in von Willebrand disease
- (1998) Haemophilia , vol.4 , Issue.SUPPL. 3 , pp. 33-39
- Dobrkovska, A.¹ Krzensk, U.² Chediak, J.R.³

13
- 0031774614
- Summary of a workshop on potency and dosage of von Willebrand factor concentrates
- (1998) Haemophilia , vol.4 , Issue.SUPPL. 3 , pp. 1-6
- Chang, A.C.¹ Rick, M.E.² Pierce, L.R.³ Weinstein, M.J.⁴

14
- 0028201807
- A revised classification of von Willebrand disease
- (1994) Thromb Haemost , vol.71 , pp. 520-525
- Sadler, J.E.¹

15
- 0342360270
- New York, NY: Society of Nuclear Medicine
- (1973) Nuclear Medicine in Clinical Pediatrics , pp. 279
- Handmaker, H.¹ Lowenstein, J.M.²

16
- 0026635692
- Recommended protocol for the study of the ex vivo biological effect of virus-inactivated plasma concentrates in patients with von Willebrand disease
- (1992) Thromb Haemost , vol.68 , pp. 84-87
- Mannucci, P.M.¹

17
- 0025687419
- A comparative study of three methods for the visualization of von Willebrand factor (VWF) multimers
- (1990) Thromb Haemost , vol.64 , pp. 569-575
- Ledford, M.R.¹ Kent, J.W.² Civantos, F.³

18
- 0001923559
- Noncompartmental pharmacokinetics
- Philadelphia, PA: Lea & Febiger
- (1984) Biopharmaceutics and Clinical Pharmacokinetics , pp. 17-28
- Gibaldi, M.¹

19
- 0003571287
- Stockholm, Sweden: Swedish Pharmaceutical Press
- (1997) nd ed. , pp. 139-149
- Gabrielsson, J.¹ Weiner, D.²

20
- 0025369659
- Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease
- (1990) Br J Haematol , vol.75 , pp. 234-239
- Cumming, A.M.¹ Fildes, S.² Cumming, I.R.³ Wensley, R.T.⁴ Redding, O.M.⁵ Burn, A.M.⁶

21
- 9544220778
- Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): Estimation of the rate of factor VIIIC synthesis
- (1996) Br J Haematol , vol.94 , pp. 740-745
- Menache, D.¹ Aronson, D.L.² Darr, F.³ Montgomery, R.R.⁴

22
- 0026650784
- Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: A cross-over randomized trial
- (1992) Blood , vol.79 , pp. 3130-3137
- Mannucci, P.M.¹ Tenconi, P.M.² Castaman, G.³ Rodeghiero, F.⁴

23
- 0023226902
- Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor
- (1987) Am J Hematol , vol.25 , pp. 55-65
- Mannucci, P.M.¹ Moia, M.² Rebulla, P.³ Altieri, D.⁴ Monteagudo, J.⁵ Castillo, R.⁶

24
- 0029551960
- Antibodies to von Willebrand factor in von Willebrand disease
- Aledort LM, Hoyer LW, Reisner JM, White GC II, eds. New York, NY: Plenum Press
- (1995) Inhibitors to coagulation factor in the 1990s , pp. 87-92
- Mannucci, P.M.¹ Federici, A.B.²

25
- 0033067602
- The transfusion-associated transmission of parvovirus B19
- (1999) Transfus Med Rev , vol.13 , pp. 194-204
- Azzi, A.¹ Morfini, M.² Mannucci, P.M.³

26
- 0028814316
- Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis
- (1995) Lancet , vol.345 , pp. 152-155
- Koster, T.¹ Blann, A.D.² Briet, E.³ Vandenbroucke, J.P.⁴ Rosendaal, F.R.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.